TScan Therapeutics, Inc.

General ticker "TCRX" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $553.5M (TTM average)

TScan Therapeutics, Inc. does not follow the US Stock Market performance with the rate: -14.4%.

Estimated limits based on current volatility of 3.9%: low 1.42$, high 1.53$

Factors to consider:

  • Earnings expected soon, date: 2025-05-12 bmo
  • Price in estimated range

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-12-31 to 2026-12-31

  • 2024-12-31 to 2025-12-31 estimated range: [1.35$, 3.78$]
  • 2025-12-31 to 2026-12-31 estimated range: [0.88$, 2.51$]

Financial Metrics affecting the TCRX estimates:

  • Negative: Non-GAAP EPS, $ of -1.14 <= 0.04
  • Negative: Operating cash flow per share per price, % of -21.17 <= 1.79
  • Negative: negative Operating income
  • Negative: negative Net income
  • Positive: Industry inventory ratio change (median), % of 0 <= 0
  • Negative: Industry operating cash flow per share per price (median), % of -21.10 <= 2.82

Similar symbols

Short-term TCRX quotes

2025-03-252025-03-262025-03-272025-03-282025-03-312025-04-012025-04-022025-04-032025-04-042025-04-072025-04-082025-04-092025-04-102025-04-112025-04-142025-04-152025-04-162025-04-172025-04-212025-04-222025-04-232025-04-242025-04-252025-04-282025-04-292025-04-302025-05-012025-05-022025-05-052025-05-0611.11.21.31.41.51.61.7
Price $

Long-term TCRX plot with estimates

246810Jul 2023Jan 2024Jul 2024Jan 2025Jul 2025Jan 2026Jul 2026Jan 2027−0.4−0.20
TCRXS&P500Health CareNon-GAAP EPS EstimateNon-GAAP EPS ActualPrice $Non-GAAP EPS $

Financial data

YTD 2022-12-31 2023-12-31 2024-12-31
Operating Revenue $13.54MM $21.05MM $2.82MM
Operating Expenses $80.17MM $114.51MM $137.64MM
Operating Income $-66.64MM $-93.46MM $-134.82MM
Non-Operating Income $0.83MM $8.48MM $7.32MM
Interest Expense $1.18MM $3.76MM $3.65MM
R&D Expense $59.82MM $88.15MM $107.35MM
Income(Loss) $-65.81MM $-84.98MM $-127.50MM
Profit(Loss)* $-65.39MM $-89.22MM $-127.50MM
Stockholders Equity $99.43MM $150.87MM $240.97MM
Assets $199.09MM $272.15MM $371.12MM
Operating Cash Flow $-66.50MM $-61.36MM $-110.82MM
Capital expenditure $4.22MM $3.15MM $3.83MM
Investing Cash Flow $-4.22MM $-60.76MM $-52.61MM
Financing Cash Flow $29.36MM $135.44MM $208.76MM
Earnings Per Share** $-2.72 $-1.36 $-1.14

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.